Universidad de Valparaiso   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Valparaíso Chile (1981)

Organization Overview

First Clinical Trial
2010
NCT01365897
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Endodontics, Faculty of Dentistry, University of Valparaíso, Chile. | Universidad de Valparaiso | Universidad de Valparaíso Chile | University Valparaiso

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis B (Phase 3)

Herpesviridae Infections (Phase 3)

Urinary Bladder, Overactive (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10